β2-adrenergic receptor gene expression as a prognostic and predictive biomarker in HER2-positive early-stage breast cancer patients enrolled in the NCCTG-N9831 (Alliance) trial
- Citation:
- Annals of Oncology vol 31 (Supplement 4) S310
- Meeting Instance:
- ESMO 2020
- Year:
- 2020
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Pharmas:
- Genentech, Genomic Health
- Grants:
- : U10CA180821, U10CA180882, U24CA196171
- Corr. Author:
- Authors:
- Rafael Caparica Yaohua Ma Claudia De Angelis François Richard Christine Desmedt Ahmad Awada Martine Piccart Edith A. Perez Alvaro Moreno-Aspitia Sunil Badve E. Aubrey Thompson Evandro de Azambuja
- Networks:
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: